secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001999371-26-004897
Event type: other
Sentiment:  positive
Materiality: 0.30
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals uplists from Nasdaq Capital Market to Global Select Market
--------------------------------------------------------------------------------

- Nasdaq approved transfer of TNXP common stock, effective March 3, 2026, ticker unchanged.
- Uplisting reflects compliance with higher financial and corporate governance standards.
- CEO Seth Lederman noted uplisting may enhance visibility, liquidity, and institutional access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937126004897/0001999371-26-004897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937126004897/tnxp-8k_030326.htm
  HTML page:      https://secwatch.observer/filing/0001999371-26-004897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer